๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors

โœ Scribed by Matthew R. Smith


Book ID
107550295
Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
243 KB
Volume
6
Category
Article
ISSN
1544-225X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Androgen deprivation therapy increases c
โœ Christopher S. Saigal; John L. Gore; Tracey L. Krupski; Janet Hanley; Matthias S ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 146 KB

## Abstract ## BACKGROUND. The use of androgen deprivation therapy (ADT) in the treatment of men with prostate cancer has risen sharply. Although cardiovascular disease is the most common reason for death among men with prostate cancer who do not die of the disease itself, data regarding the effec

Pathologic changes associated with andro
โœ William M. Murphy; Mark S. Soloway; George H. Barrows ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 934 KB

Prostate glands exposed to androgen deprivation with leuprolide -+ flutamide were evaluated for pathologic changes which might be related to therapy. Comparing pretreatment and posttreatment tissue by visual discrimination using light microscopic study revealed treatment-related alterations in the s